Dr. Rohatgi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 L St, #300
Sacramento, CA 95816Phone+1 916-453-3300
Education & Training
- University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1999 - 2002
- UMass Chan Medical SchoolResidency, Internal Medicine, 1993 - 1996
- All India Institute of Medical SciencesClass of 1990
Certifications & Licensure
- CA State Medical License 2002 - 2026
- OH State Medical License 1998 - 2004
- FL State Medical License 1996 - 2002
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsOlaparib in Patients With Metastatic Prostate Cancer With/Mutation: Results From the TAPUR Study.Eddy S Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat
JCO Precision Oncology. 2023-02-01 - 2 citationsNivolumab Plus Ipilimumab in Patients With Solid Tumors WithMutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.Nitin Rohatgi, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam
JCO Precision Oncology. 2023-09-01 - 1 citationsSunitinib in Patients With Breast Cancer WithorAmplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn
JCO Precision Oncology. 2024-02-01
Professional Memberships
- Member
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: